Programme overview

• Keynote speeches from the two CEOs, highlighting the latest challenges and opportunities in oncology, with a special focus on comparing the approaches and innovations at Gustave Roussy and the VHIO

Early drug development 

• Discussions on innovations and strategies in early-stage drug development
• Covering clinical trials and regulatory pathways

Patients’ avatars 

• Insights into the transformative potential of digital patient avatars in personalized medicine and clinical research

Survivorship 

• Analysis of survivorship challenges in both adults and pediatric patients
• Emphasizing long-term care, quality of life
• Post-treatment follow-up

Liquid biopsies

• Overview of advancements in liquid biopsies
• Focusing on key projects in personalized precision medicine

Artificial Intelligence & Pre-clinical research

• A collaborative workshop exploring the integration of AI in preclinical research, focusing on accelerating drug discovery, improving data analysis, and enhancing predictive modeling for better decision-making in early-stage oncology

Patient inclusion and representation in care and in research 

• A group session focusing on patient engagement in research project development, empowering them to take an active role in clinical trial participation and decision-making

Place of surgery in oncological care pathways

• A collaborative discussion on the evolving role of surgery in oncology, highlighting innovations in surgical techniques and technologies that are reshaping oncological care pathways

Cellular therapies

• Talks about the latest progress and future prospects of cellular therapies like CAR-T cells in clinical practice

• Wrap-up of the day’s key insights, with a focus on future projects